|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lepage C, Sant M, Verdecchia A, Forman D,
Esteve J and Faivre J; EUROCARE working group, : Operative
mortality after gastric cancer resection and long-term survival
differences across Europe. Br J Surg. 97:235–239. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lin JX, Lin JP, Xie JW, Wang JB, Lu J,
Chen QY, Cao LL, Lin M, Tu R, Zheng CH, et al: Prognostic value and
association of sarcopenia and systemic inflammation for patients
with gastric cancer following radical gastrectomy. Oncologist.
24:e1091–e1101. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Squires MH III, Kooby DA, Poultsides GA,
Weber SM, Bloomston M, Fields RC, Pawlik TM, Votanopoulos KI,
Schmidt CR, Ejaz A, et al: Effect of perioperative transfusion on
recurrence and survival after gastric cancer resection: A
7-institution analysis of 765 patients from the US gastric cancer
collaborative. J Am Coll Surg. 221:767–777. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Piazuelo MB and Correa P: Gastric cáncer:
Overview. Colomb Med (Cali). 44:192–201. 2013.PubMed/NCBI
|
|
6
|
Sakurai K, Kubo N, Tamura T, Toyokawa T,
Amano R, Tanaka H, Muguruma K, Yashiro M, Maeda K, Hirakawa K and
Ohira M: Adverse effects of low preoperative skeletal muscle mass
in patients undergoing gastrectomy for gastric cancer. Ann Surg
Oncol. 24:2712–2719. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kudou K, Saeki H, Nakashima Y, Edahiro K,
Korehisa S, Taniguchi D, Tsutsumi R, Nishimura S, Nakaji Y, Akiyama
S, et al: Prognostic significance of sarcopenia in patients with
esophagogastric junction cancer or upper gastric cancer. Ann Surg
Oncol. 24:1804–1810. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yamamoto K, Hirao M, Nishikawa K, Omori T,
Yanagimoto Y, Shinno N, Sugimura K, Miyata H, Wada H, Takahashi H,
et al: Sarcopenia is associated with impaired overall survival
after gastrectomy for elderly gastric cancer. Anticancer Res.
39:4297–4303. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nishigori T, Tsunoda S, Obama K, Hisamori
S, Hashimoto K, Itatani Y, Okada K and Sakai Y: Optimal cutoff
values of skeletal muscle index to define sarcopenia for prediction
of survival in patients with advanced gastric cancer. Ann Surg
Oncol. 25:3596–3603. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sato T, Aoyama T, Hayashi T, Segami K,
Kawabe T, Fujikawa H, Yamada T, Yamamoto N, Oshima T, Rino Y, et
al: Impact of preoperative hand grip strength on morbidity
following gastric cancer surgery. Gastric Cancer. 19:1008–1015.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tegels JJ, van Vugt JL, Reisinger KW,
Hulsewe KW, Hoofwijk AG, Derikx JP and Stoot JH: Sarcopenia is
highly prevalent in patients undergoing surgery for gastric cancer
but not associated with worse outcomes. J Surg Oncol. 112:403–407.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Renehan AG, Tyson M, Egger M, Heller RF
and Zwahlen M: Body-mass index and incidence of cancer: A
systematic review and meta-analysis of prospective observational
studies. Lancet. 371:569–578. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tchernof A and Després JP: Pathophysiology
of human visceral obesity: An update. Physiol Rev. 93:359–404.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Amato MC, Giordano C, Galia M, Criscimanna
A, Vitabile S, Midiri M and Galluzzo A; AlkaMeSy Study Group, :
Visceral adiposity index: A reliable indicator of visceral fat
function associated with cardiometabolic risk. Diabetes Care.
33:920–922. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Després JP and Lemieux I: Abdominal
obesity and metabolic syndrome. Nature. 444:881–887. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Pou KM, Massaro JM, Hoffmann U, Vasan RS,
Maurovich-Horvat P, Larson MG, Keaney JF Jr, Meigs JB, Lipinska I,
Kathiresan S, et al: Visceral and subcutaneous adipose tissue
volumes are cross-sectionally related to markers of inflammation
and oxidative stress: The framingham heart study. Circulation.
116:1234–1241. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Alemán JO, Eusebi LH, Ricciardiello L,
Patidar K, Sanyal AJ and Holt PR: Mechanisms of obesity-induced
gastrointestinal neoplasia. Gastroenterology. 146:357–373. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Demark-Wahnefried W, Platz EA, Ligibel JA,
Blair CK, Courneya KS, Meyerhardt JA, Ganz PA, Rock CL, Schmitz KH,
Wadden T, et al: The role of obesity in cancer survival and
recurrence. Cancer Epidemiol Biomarkers Prev. 21:1244–1259. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cozzo AJ, Fuller AM and Makowski L:
Contribution of adipose tissue to development of cancer. Compr
Physiol. 8:237–282. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li XT, Tang L, Chen Y, Li YL, Zhang XP and
Sun YS: Visceral and subcutaneous fat as new independent predictive
factors of survival in locally advanced gastric carcinoma patients
treated with neo-adjuvant chemotherapy. J Cancer Res Clin Oncol.
141:1237–1247. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang SL, Ma LL, Chen XY, Zhou DL, Li B,
Huang DD, Yu Z, Shen X and Zhuang CL: Impact of visceral fat on
surgical complications and long-term survival of patients with
gastric cancer after radical gastrectomy. Eur J Clin Nutr.
72:436–445. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Harada K, Baba Y, Ishimoto T, Kosumi K,
Tokunaga R, Izumi D, Ida S, Imamura Y, Iwagami S, Miyamoto Y, et
al: Low visceral fat content is associated with poor prognosis in a
database of 507 upper gastrointestinal cancers. Ann Surg Oncol.
22:3946–3953. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li L, Li W, Xu D, He H, Yang W, Guo H, Liu
X, Ji W, Song C, Xu H, et al: Association between visceral fat area
and cancer prognosis: A population-based multicenter prospective
study. Am J Clin Nutr. 118:507–517. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
López MJ, Carbajal J, Alfaro AL, Saravia
LG, Zanabria D, Araujo JM, Quispe L, Zevallos A, Buleje JL, Cho CE,
et al: Characteristics of gastric cancer around the world. Crit Rev
Oncol Hematol. 181:1038412023. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lin YC, Lin G and Yeh TS:
Visceral-to-subcutaneous fat ratio independently predicts the
prognosis of locally advanced gastric cancer–highlighting the role
of adiponectin receptors and PPARα, β/δ, ɤ. Eur J Surg Oncol.
47:3064–3073. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tanaka K, Miyashiro I, Yano M, Kishi K,
Motoori M, Shingai T, Noura S, Ohue M, Ohigashi H and Ishikawa O:
Visceral fat changes after distal gastrectomy according to type of
reconstruction procedure for gastric cancer. World J Surg Oncol.
11:1462013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Amin MB, Greene FL, Edge SB, Compton CC,
Gershenwald JE, Brookland RK, Meyer L, Gress DM, Byrd DR and
Winchester DP: The eighth edition AJCC cancer staging manual:
Continuing to build a bridge from a population-based to a more
‘personalized’ approach to cancer staging. CA Cancer J Clin.
67:93–99. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Malietzis G, Currie AC, Athanasiou T,
Johns N, Anyamene N, Glynne-Jones R, Kennedy RH, Fearon KC and
Jenkins JT: Influence of body composition profile on outcomes
following colorectal cancer surgery. Br J Surg. 103:572–580. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Rowan CR, McManus J, Boland K and O'Toole
A: Visceral adiposity and inflammatory bowel disease. Int J
Colorectal Dis. 36:2305–2319. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li S, Liao Z, He K, Shen Y, Hu S and Li Z:
Association of sex-specific abdominal adipose tissue with WHO/ISUP
grade in clear cell renal cell carcinoma. Insights Imaging.
14:1942023. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Choe EK, Lee Y, Kang HY, Choi SH and Kim
JS: Association between CT-measured abdominal skeletal muscle mass
and pulmonary function. J Clin Med. 8:6672019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Vongsuvanh R, George J, Qiao L and van der
Poorten D: Visceral adiposity in gastrointestinal and hepatic
carcinogenesis. Cancer Lett. 330:1–10. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Michaud A, Drolet R, Noël S, Paris G and
Tchernof A: Visceral fat accumulation is an indicator of adipose
tissue macrophage infiltration in women. Metabolism. 61:689–698.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wellen KE and Hotamisligil GS:
Obesity-induced inflammatory changes in adipose tissue. J Clin
Invest. 112:1785–1788. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Bråkenhielm E, Veitonmäki N, Cao R, Kihara
S, Matsuzawa Y, Zhivotovsky B, Funahashi T and Cao Y:
Adiponectin-induced antiangiogenesis and antitumor activity involve
caspase-mediated endothelial cell apoptosis. Proc Natl Acad Sci
USA. 101:2476–2481. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Roberts DL, Dive C and Renehan AG:
Biological mechanisms linking obesity and cancer risk: New
perspectives. Annu Rev Med. 61:301–316. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wagner M and Dudley AC: A three-party
alliance in solid tumors: Adipocytes, macrophages and vascular
endothelial cells. Adipocyte. 2:67–73. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Nieman KM, Romero IL, Van Houten B and
Lengyel E: Adipose tissue and adipocytes support tumorigenesis and
metastasis. Biochim Biophys Acta. 1831:1533–1541. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Meyer KA, Neeley CK, Baker NA, Washabaugh
AR, Flesher CG, Nelson BS, Frankel TL, Lumeng CN, Lyssiotis CA,
Wynn ML, et al: Adipocytes promote pancreatic cancer cell
proliferation via glutamine transfer. Biochem Biophys Rep.
7:144–149. 2016.PubMed/NCBI
|
|
40
|
Martinez-Outschoorn UE, Sotgia F and
Lisanti MP: Power surge: Supporting cells ‘fuel’ cancer cell
mitochondria. Cell Metab. 15:4–5. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Brown JC, Caan BJ, Prado CM, Cespedes
Feliciano EM, Xiao J, Kroenke CH and Meyerhardt JA: The association
of abdominal adiposity with mortality in patients with stage I–III
colorectal cancer. J Natl Cancer Inst. 112:377–383. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Montano-Loza AJ, Mazurak VC, Ebadi M,
Meza-Junco J, Sawyer MB, Baracos VE and Kneteman N: Visceral
adiposity increases risk for hepatocellular carcinoma in male
patients with cirrhosis and recurrence after liver transplant.
Hepatology. 67:914–923. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Moon HG, Ju YT, Jeong CY, Jung EJ, Lee YJ,
Hong SC, Ha WS, Park ST and Choi SK: Visceral obesity may affect
oncologic outcome in patients with colorectal cancer. Ann Surg
Oncol. 15:1918–1922. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Fearon K, Arends J and Baracos V:
Understanding the mechanisms and treatment options in cancer
cachexia. Nat Rev Clin Oncol. 10:90–99. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Penna F, Minero VG, Costamagna D, Bonelli
G, Baccino FM and Costelli P: Anti-cytokine strategies for the
treatment of cancer-related anorexia and cachexia. Expert Opin Biol
Ther. 10:1241–1250. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Prado CMM, Lieffers JR, McCargar LJ,
Reiman T, Sawyer MB, Martin L and Baracos VE: Prevalence and
clinical implications of sarcopenic obesity in patients with solid
tumours of the respiratory and gastrointestinal tracts: A
population-based study. Lancet Oncol. 9:629–635. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Charette N, Vandeputte C, Ameye L, Bogaert
CV, Krygier J, Guiot T, Deleporte A, Delaunoit T, Geboes K, Van
Laethem JL, et al: Prognostic value of adipose tissue and muscle
mass in advanced colorectal cancer: A post hoc analysis of two
non-randomized phase II trials. BMC Cancer. 19:1342019. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Frontera WR and Ochala J: Skeletal muscle:
A brief review of structure and function. Calcif Tissue Int.
96:183–195. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Sánchez-Torralvo FJ, Ruiz-García I,
Contreras-Bolívar V, González-Almendros I, Ruiz-Vico M,
Abuín-Fernández J, Barrios M, Alba E and Olveira G: CT-determined
sarcopenia in GLIM-defined malnutrition and prediction of 6-month
mortality in cancer inpatients. Nutrients. 13:26472021. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Endo T, Momoki C, Yamaoka M, Hachino S,
Iwatani S, Kiyota S, Tanaka H and Habu D: Validation of skeletal
muscle volume as a nutritional assessment in patients with gastric
or colorectal cancer before radical surgery. J Clin Med Res.
9:844–859. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Ma BW, Chen XY, Fan SD, Zhang FM, Huang
DD, Li B, Shen X, Zhuang CL and Yu Z: Impact of sarcopenia on
clinical outcomes after radical gastrectomy for patients without
nutritional risk. Nutrition. 61:61–66. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Huang DD, Wang SL, Zhuang CL, Zheng BS, Lu
JX, Chen FF, Zhou CJ, Shen X and Yu Z: Sarcopenia, as defined by
low muscle mass, strength and physical performance, predicts
complications after surgery for colorectal cancer. Colorectal Dis.
17:O256–O264. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Zhuang CL, Shen X, Zou HB, Dong QT, Cai
HY, Chen XL, Yu Z and Wang SL: EWGSOP2 versus EWGSOP1 for
sarcopenia to predict prognosis in patients with gastric cancer
after radical gastrectomy: Analysis from a large-scale prospective
study. Clin Nutr. 39:2301–2310. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Rinninella E, Cintoni M, Raoul P, Pozzo C,
Strippoli A, Bria E, Tortora G, Gasbarrini A and Mele MC: Muscle
mass, assessed at diagnosis by L3-CT scan as a prognostic marker of
clinical outcomes in patients with gastric cancer: A systematic
review and meta-analysis. Clin Nutr. 39:2045–2054. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Aurello P, Tierno SM, Berardi G, Tomassini
F, Magistri P, D'Angelo F and Ramacciato G: Value of preoperative
inflammation-based prognostic scores in predicting overall survival
and disease-free survival in patients with gastric cancer. Ann Surg
Oncol. 21:1998–2004. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Diakos CI, Charles KA, McMillan DC and
Clarke SJ: Cancer-related inflammation and treatment effectiveness.
Lancet Oncol. 15:e493–e503. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Okugawa Y, Toiyama Y, Yamamoto A,
Shigemori T, Ide S, Kitajima T, Fujikawa H, Yasuda H, Hiro J,
Yoshiyama S, et al: Lymphocyte-C-reactive protein ratio as
promising new marker for predicting surgical and oncological
outcomes in colorectal cancer. Ann Surg. 272:342–351. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Feliciano EMC, Kroenke CH, Meyerhardt JA,
Prado CM, Bradshaw PT, Kwan ML, Xiao J, Alexeeff S, Corley D,
Weltzien E, et al: Association of systemic inflammation and
sarcopenia with survival in nonmetastatic colorectal cancer:
Results from the C SCANS study. JAMA Oncol. 3:e1723192017.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Pergialiotis V, Thomakos N, Frountzas M,
Haidopoulos D, Loutradis D and Rodolakis A: Perioperative blood
transfusion and ovarian cancer survival rates: A meta-analysis
based on univariate, multivariate and propensity score matched
data. Eur J Obstet Gynecol Reprod Biol. 252:137–143. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Latif MJ, Tan KS, Molena D, Huang J, Bott
MJ, Park BJ, Adusumilli PS, Rusch VW, Bains MS, Downey RJ, et al:
Perioperative blood transfusion has a dose-dependent relationship
with disease recurrence and survival in patients with non-small
cell lung cancer. J Thorac Cardiovasc Surg. 157:2469–2477. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
McSorley ST, Tham A, Dolan RD, Steele CW,
Ramsingh J, Roxburgh C, Horgan PG and McMillan DC: Perioperative
blood transfusion is associated with postoperative systemic
inflammatory response and poorer outcomes following surgery for
colorectal cancer. Ann Surg Oncol. 27:833–843. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Maersk M, Belza A, Stødkilde-Jørgensen H,
Ringgaard S, Chabanova E, Thomsen H, Pedersen SB, Astrup A and
Richelsen B: Sucrose-sweetened beverages increase fat storage in
the liver, muscle, and visceral fat depot: A 6-mo randomized
intervention study. Am J Clin Nutr. 95:283–289. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Slominski RM, Raman C, Chen JY and
Slominski AT: How cancer hijacks the body's homeostasis through the
neuroendocrine system. Trends Neurosci. 46:263–275. 2023.
View Article : Google Scholar : PubMed/NCBI
|
